ASH 2012 Multiple Myeloma Update with Dr. William Bensinger
In this interview from the 2012 American Society of Hematology (ASH) Annual Meeting, Dr. William Bensinger discusses the drug combination of Carfilzomib, Pomalidomide, and Dexamethasone. He explains the history and use of these drugs and how they were used in a phase one trial. The study gives patients less toxic therapy, a combination of more powerful medicines, and new hope. Learn more about this combination therapy for multiple myeloma.
Limiting Myeloma Treatment Side Effects
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Drs. William Bensinger and Noopur Raje discuss ways to limit the side effects of treatment for myeloma with Andrew Schorr from Patient Power. Dr. Raje states that the goal is not just to live longer, but to live longer well. Because every patient experiences different side effects from the treatment of the disease, Dr. Raje says the key is communication with your medical team, including nurses. Listen for more tips on managing side effects of myeloma treatment.
Multiple Myeloma Testing and Personalized Treatment
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Drs. William Bensinger and Dr. Noopur Raje discuss testing for the treatment of myeloma with Andrew Schorr from Patient Power. With the heterogeneity of the disease, adjusting the drug schedule and combination for the individual patient is the key to treatment efficacy and the control of side effects. Dr. Raje describes the panel of tests used to determine the appropriate individualized treatment regimen.
Stem Cell Transplant for Multiple Myeloma
In this video from our ""Living Well With Multiple Myeloma"" event held at SCCA in November 2011, Dr. William Bensinger of Seattle Cancer Care Alliance, discusses the treatment of myeloma with stem cell transplant. He describes an autologous transplant, where high doses of drugs such as melphalan to eradicate the myeloma, and outlines the side effects. Dr. Bensinger tells about clinical trials which are trying to determine if transplants as part of the initial therapy or later in the course of disease treatment is more effective.